This dataset contains information about fatalities attributed to COVID-19 in Belgium. The data is organised on a weekly basis and provides details on the age of the deceased individuals, the region in which they died, and the region where they were residents.
This dataset contains information about fatalities attributed to COVID-19 in Belgium. The data is structured to provide details on a weekly basis, specifying the age of the deceased individuals, their region of residence within Belgium, and the place where they died (e.g., hospitals, long-term care facilities, private residences).
The Epilabo project consists of a network of sentinel clinical microbiology laboratories coordinated by Sciensano. It encompasses about 40 different pathogens and is used to follow the epidemiology of infectious diseases in Belgium. Laboratories participate on a voluntary basis. Cases are reported individually in this surveillance.
This dataset provides information about the number of fatalities attributed to COVID-19 in Belgium. The data is likely organised based on the date of death, geographical region within Belgium, specific age groups, and the gender of the deceased individuals.
This dataset contains information on fatalities attributed to COVID-19 in Belgium. The data is structured to provide details on a weekly basis, specifying the age of the deceased individuals, their region of residence within Belgium, and the classification of their COVID-19 cases (e.g., confirmed, probable).
The national wastewater-based epidemiological surveillance of SARS-CoV-2 monitors the SARS-CoV-2 presence in several wastewater treatment plants across Belgium. This dataset contains the catchment areas per wastewater treatment plant since the beginning of the surveillance in September 2020.
The national wastewater-based epidemiological surveillance of SARS-CoV-2 monitors the SARS-CoV-2 presence in several wastewater treatment plants across Belgium. This dataset contains the results per treatment plant since the beginning of the surveillance in September 2020. The results consist in the SARS-CoV2 concentrations over time as well as other data needed for the interpretations such as the flow rates of the treatment plants and their covering populations.
A collection of data (lab analysis and surveys) from a Belgian cohort of staff and residents of nursing homes, subsample of the PICOV study. Data are about participants' immunity previous and after COVID-19 vaccination (dose 1 , 2 and 3) using mRNA COVID-19 vaccine BTB162b2. Adverse events linked to the vaccination are available. Participants' survey with their health status is also available.
A collection of data (lab analysis and surveys) from a Belgian cohort of healthy and vulnerable population (elderly people, lung transplant recipients, kidney transplant recipients, immunodialyzed) people. Data are coming from a following of the participants' immunological response to COVID-19 analyzed 3 times a year (February, June, October). Participants' survey with their health status is also available.
A collection of data (lab analysis and surveys) from a Belgian cohort of healthy people working at five sites across Belgium of the ‘External Department of Prevention and Protection at work’ of Mensura and at Carglass company. Data are about participants' immunity previous and after COVID-19 vaccination (dose 3) using mRNA COVID-19 vaccine BTB162b2. Redu-VAC is a randomised, multicenter, non-inferiority study investigating safety, reactogenicity and immunogenicity of a fractional booster dose (10µg versus 30µg) of the vaccine. Adverse events linked to the vaccination are available.
